08/05/2008
Xanodyne Achieves Positive Efficacy Results in Pivotal Phase 3 Studies of Proprietary Modified Release Oral Tranexamic Acid Product Candidate for Heavy Menstrual Bleeding
07/22/2008
Xanodyne Receives Approvable Letter From the U.S. Food and Drug Administration for ZIPSOR™ (diclofenac potassium) Capsules
07/01/2008
Vertafore Announces Agreement to Acquire Sircon
[
more news
]
HOME
|
WHAT WE DO
|
OUR TEAM
|
OUR PORTFOLIO
|
CONTACT US
|
NEWS
©2008 Blue Chip Venture Company. Site Design:
Core Five
.